Institution statistics

EUROPEAN CANCER PATIENT COALITION -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 17
As coordinator: 0
As participant: 17
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 19.163.125 490.000 2
2020 0 16.194.901 395.104 2
2019 0 31.888.742 552.812 5
2018 0 9.727.723 79.994 2
2017 0 19.404.068 225.957 4
2016 0 11.782.965 246.250 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
TTOPSTART BV6
JANSSEN PHARMACEUTICA NV5
KATHOLIEKE UNIVERSITEIT LEUVEN4
ASTELLAS PHARMA EUROPE BV3
BAYER3
F HOFFMANNLA ROCHE3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
NOVARTIS PHARMA3
PFIZER LIMITED3
STICHTING KATHOLIEKE UNIVERSITEIT3
STICHTING VUMC3
TECHNISCHE UNIVERSITAET MUENCHEN3
ACADEMISCH ZIEKENHUIS GRONINGEN2
CELGENE MANAGEMENT SARL2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITEIT ROTTERDAM2
EUROPEAN ASSOCIATION OF PALLIATIVE CARE2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
HEALTH INNOVATION VENTURES BV2
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
KING'S COLLEGE LONDON2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
TAKEDA DEVELOPMENT CENTRE EUROPE2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE GENERAL HOSPITAL CORPORATION2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF TAMPERE2
VRIJE UNIVERSITEIT BRUSSEL2
ABBVIE1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS MAASTRICHT1
ACTELION PHARMACEUTICALS1
ALEXANDER FLEMING1
ALTRANPORTUGAL1
AMGEN1
AMGEN LIMITED1
AMPHERA BV1
ANAXOMICS BIOTECH S L1
ANTAROS MEDICAL AB1
ARISTOTELIAN UNIVERSITY OF THESSALONIKI1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSOCIATION EISBM1
ASTRAZENECA AB1
AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA1
BAYER AKTIENGESELLSCHAFT1
BAYER PHARMA1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOSCI CONSULTING BVBA1
BIOXPEDIA AS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CABALLERO LLANO CARMELO CESAR1
CANCER INTELLIGENCE LIMITED1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE OSCAR LAMBRET1
CLINIQUES UNIVERSITAIRES SAINTLUC1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COVANCE LABORATORIES1
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY1
CSL BEHRING1
CYBERLENS BV1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG1
DIN DEUTSCHES INSTITUT FUER NORMUNG EV1
DRESDEN UNIVERSITY OF TECHNOLOGY1
DUALTPHARMA1
ELSEVIER BV1
EMC ISRAEL DEVELOPMENT CENTER1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN PATIENTS' FORUM1
EXOSOMICS SIENA1
FACTORYCRO BV1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA1
FOLKEHELSEINSTITUTTET1
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI1
FUNDACAO D ANNA SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
Constancy:

Total number of partners:303

Partner loyalty:
Frequent Partner: (> 2 projects): 48
Rare Partner: 255

Frequent / Rare Partner Ratio: 0.19

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2021-01-01International consortium for integrative genomics prediction INTERVENEparticipant10.434.94018
2020-01-01Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management QUALITOPparticipant5.196.77314
2020-01-01Integrated and standardized NGS workflows for Personalised therapy Instand-NGS4Pparticipant10.998.12818
2019-12-01A Collective Intelligence Platform to Support Cancer Champions LifeChampsparticipant4.999.91515
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2019-01-01The use of proportional palliative sedation for the relief of refractory symptoms: an international multicenter study PalliativeSedationparticipant4.033.52010
2019-01-01CeLac and European consortium for a personalized medicine approach to Gastric Cancer LEGACyparticipant3.577.43111
2019-01-01Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial DIAdICparticipant4.277.87511
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00035
2018-01-01European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools ELBAparticipant3.727.72321
2017-12-01A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISAparticipant6.000.0006
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-01-01DC-based immunotherapy to treat Malignant Mesothelioma H2020MM04participant5.782.9658
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum